This is a basic article for medical students and other non-radiologists
Prostate cancer, also called carcinoma of the prostate or prostate carcinoma, is the commonest malignant tumor in men. It is primarily a disease of old age and many men remain asymptomatic.
On this page:
Reference article
This is a summary article; read more in our article on prostate cancer.
Summary
-
epidemiology
- primarily disease of elderly men
-
presentation
- elevated PSA without clinical symptoms
- large prostate on rectal examination
- urinary symptoms
- back pain
-
pathophysiology
- 95% prostatic adenocarcinoma
- spread
- local invasion
- lymphatic spread
- hematogenous spread
- bone (90%)
- use Gleason score
-
investigation
- ultrasound-assisted prostatic biopsy
- local and whole-body staging
-
treatment
- depends on whether there is spread and if the patient is symptomatic
- options include
- radical prostatectomy
- brachytherapy (insertion of radioactive rods into the prostate)
- external beam radiotherapy
Role of imaging
- assist in a successful biopsy
- MR for local staging, e.g. is there extracapsular spread?
- whole-body staging
Radiographic features
Ultrasound
- a hypoechoic region in the periphery of the gland
- ultrasound-guided transrectal biopsy
MRI
- used for local staging
- determine whether tumor extends out with the prostatic capsule
- can be used to guide biopsy if the US-guided biopsy is negative
CT
- not useful for detection of in situ prostatic cancer
- can be useful to detect enlarged lymph nodes
Bone scan
- used for identifying distant bone metastases
PSMA PET-CT
- used for staging nodal and metastatic disease
- assist with radiotherapy planning
- detection of recurrence in patients with rising PSA post-treatment